New Era Begins as Aurora Resurgence Wins Approval to Acquire Cardiac Science Corporation

WAUKESHA, Wis., Jan. 11, 2016 /PRNewswire/ — Aurora Resurgence, an affiliate of Aurora Capital Group, a Los Angeles-based private equity firm managing over $2 billion of assets, is pleased to announce the acquisition of the assets of Cardiac Science Corporation in a court-approved sale. Cardiac Science is a global leader in the manufacturing and marketing of automated external defibrillators (AEDs) for the public access, education, police, and fire and rescue markets.

“We are tremendously excited to partner with Aurora Resurgence to complete this transaction and enter into a new phase of growth,” said Al Ford of Cardiac Science. “We emerge from this restructuring with a clean, well-capitalized balance sheet, a strong growth platform with industry-leading products and services, and a supportive partner that shares our long-term goals. This transaction and partnership present a bright future for Cardiac Science’s customers, distribution partners, suppliers and employees.”

Sean Ozbolt, Partner at Aurora Resurgence, commented, “Cardiac Science is an innovative supplier of AEDs with best-in-class products and a world-class team. The company has a significant opportunity to expand in the high-growth U.S. and international public access defibrillation markets. We look forward to supporting the company’s global growth vision and its commitment to helping to save lives.”

About Cardiac Science
Cardiac Science develops, manufactures, and markets automated external defibrillators (AEDs) and related parts, components and accessories. The company also provides a comprehensive portfolio of training, maintenance, and support services for AED customers. Cardiac Science is headquartered in Waukesha, Wisconsin. The company has operations in North America, Europe and Asia and has an installed base of over 500,000 units in nearly 100 countries worldwide.